Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ATAI Life Sciences N.V.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1/A
Total revenues   [+]0.220.40.03.1
            Revenue growth  -98.9% -100.0% 
Cost of goods sold  0.50.00.015.8
Gross profit  -0.320.40.0-12.8
            Gross margin  -114.6%100.0% -413.7%
Selling, general and administrative   [+]70.492.780.75.1
Research and development  74.348.011.4 
Equity in earnings  -16.0-58.6-76.5 
Other operating expenses  -0.115.512.0 
EBITDA   [+]-160.6-194.3-180.6-17.8
            EBITDA margin  -68937.8%-953.6% -578.5%
Depreciation and amortization  0.20.00.00.0
EBIT   [+]-160.8-194.4-180.7-17.8
            EBIT margin  -69009.9%-953.9% -578.7%
Interest income  0.50.20.10.0
Other income (expense), net   [+]25.157.678.80.4
Pre-tax income  -135.2-136.6-101.8-17.5
Income taxes  -6.2-4.0-0.30.0
            Tax rate  4.6%2.9%0.3%0.0%
Minority interest  -5.0-6.4-8.8 
Net income  -152.4-167.8-169.8-24.4
            Net margin  -65401.3%-823.6% -790.7%
   
Basic EPS   [+]($0.98)($1.21)($1.83) 
Diluted EPS   [+]($0.98)($1.21)($1.83) 
   
Shares outstanding (basic)   [+]155.7138.393.0 
Shares outstanding (diluted)   [+]155.7138.393.0 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy